focus -WSS

focus

author：leisure time 2025-10-01 04:45:10 - browse：4943

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： UpToDate has a racism problem: Dr. Stanley Goldfarb

WSS

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Churchill Downs extends trainer Bob Baffert's ban through 2024

Use doctors trained outside the U.S. to ease the physician shortage

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Canadians with cystic fibrosis outlive Americans by a decade

Some in Scotland's Orkney Islands want to return to Norway after 550 years

focus

focus

focus

Psychedelics group wrestles with new pharma identity

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Affirmative action in medical school literally saved lives

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

After affirmative action ruling, medical educators look to 'holistic review'

Security flaws in third

How to save PrEP access — and even expand it

Undocumented workers face uncertainty as immigration law takes effect in Florida

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

NASA releases new images of 'fingerprint

explore

Some in Scotland's Orkney Islands want to return to Norway after 550 years

A letter from the executive editor: The 2023 STATUS List

Some in Scotland's Orkney Islands want to return to Norway after 550 years

A letter from the executive editor: The 2023 STATUS List

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

4 dead, 2 in stable condition in Philadelphia shooting: Police

Wikipedia

Wikipedia

focus

leisure time